Lupin receives warning letter from USFDA for its Somerset facility
On June 13, the drug maker Lupin received a warning letter from the USFDA for the company’s Somerset facility in…
On June 13, the drug maker Lupin received a warning letter from the USFDA for the company’s Somerset facility in…
The Indian multinational pharmaceuticals company, Lupin announced on Thursday that it is entering the segment of digital healthcare in India.…